Dabrafenib, trametinib found more effective in pediatric glioma with BRAF V600
Dabrafenib plus trametinib results in significantly more responses and longer progression-free survival than standard chemotherapy for pediatric patients with low-grade glioma with BRAF V600 mutations, according to a study ...
2 hours ago
0
0